608. Titus L. J., Clough-Gorr K., Mackenzie T. A., Perry A., Spencer S. K., Weiss J., Abrahams-Gessel S., Ernstoff M. S. Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth // Br J Dermatol. ‒ 2013. ‒ T. 168, № 3. ‒ C. 571-6.
609. Pflugfelder A., Kochs C., Blum A., Capellaro M., Czeschik C., Dettenborn T., Dill D., Dippel E., Eigentler T., Feyer P., Follmann M., Frerich B., Ganten M. K., Gartner J., Gutzmer R., Hassel J., Hauschild A., Hohenberger P., Hubner J., Kaatz M., Kleeberg U. R., Kolbl O., Kortmann R. D., Krause-Bergmann A., Kurschat P., Leiter U., Link H., Loquai C., Loser C., Mackensen A., Meier F., Mohr P., Mohrle M., Nashan D., Reske S., Rose C., Sander C., Satzger I., Schiller M., Schlemmer H. P., Strittmatter G., Sunderkotter C., Swoboda L., Trefzer U., Voltz R., Vordermark D., Weichenthal M., Werner A., Wesselmann S., Weyergraf A. J., Wick W., Garbe C., Schadendorf D., German Dermatological S., DermatologicCooperative Oncology G. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma" // J Dtsch Dermatol Ges. ‒ 2013. ‒ T. 11 Suppl 6. ‒ C. 1-116, 1-126.
610. DeRose E. R., Pleet A., Wang W., Seery V. J., Lee M. Y., Renzi S., Sullivan R. J., Atkins M. B. Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma // Melanoma Res. ‒ 2011. ‒ T. 21, № 4. ‒ C. 364-9.
611. Maeda T., Sato K., Minami H., Taguchi H., Yoshikawa K. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum // J Invest Dermatol. ‒ 1997. ‒ T. 109, № 3. ‒ C. 306-9.
612. Tomatir A. G., Sorkun H. C., Demirhan H., Akdag B. Genetics and genetic counseling: practices and opinions of primary care physicians in Turkey // Genet Med. ‒ 2007. ‒ T. 9, № 2. ‒ C. 130-5.
613. Bloom A. D. Genetic counseling in pediatric dermatology // Mod Probl Paediatr. ‒ 1975. ‒ T. 17. ‒ C. 1-5.
614. Soura E., Eliades P. J., Shannon K., Stratigos A. J., Tsao H. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome // J Am Acad Dermatol. ‒ 2016. ‒ T. 74, № 3. ‒ C. 395-407; quiz 408-10.
615. Borroni R. G., Manganoni A. M., Grassi S., Grasso M., Diegoli M., Giorgianni C., Favalli V., Pavoni L., Cespa M., Arbustini E. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy // Melanoma Res. ‒ 2017. ‒ T. 27, № 2. ‒ C. 97-103.
616. Belysheva T. S., Vishnevskaya Y. V., Nasedkina T. V., Emelyanova M. A., Abramov I. S., Orlova K. V., Lubchenko L. N., Utyashev I. A., Doroshenko M. B., Demidov L. V., Aliev M. D. Melanoma arising in a Giant congenital melanocytic nevus: two case reports // Diagn Pathol. ‒ 2019. ‒ T. 14, № 1. ‒ C. 21.
617. Kinsler V. A., Thomas A. C., Ishida M., Bulstrode N. W., Loughlin S., Hing S., Chalker J., McKenzie K., Abu-Amero S., Slater O., Chanudet E., Palmer R., Morrogh D., Stanier P., Healy E., Sebire N. J., Moore G. E. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS // J Invest Dermatol. ‒ 2013. ‒ T. 133, № 9. ‒ C. 2229-36.
618. Schneider J. The teaspoon rule of applying sunscreen // Arch Dermatol. ‒ 2002. ‒ T. 138, № 6. ‒ C. 838-9.
619. Karnofsky D. A., Burchenal J. H. The clinical evaluation of chemotherapeutic agents in cancer // Evaluation of chemotherapeutic agents / MacLeod C. ‒ New York: Columbia University Press, 1949. ‒ C. 191-205.
620. Гомболевский В. Методические рекомендации по применению критериев ответа солидных опухолей на химиотерапевтическое лечение (RECIST 1.1) // Методические рекомендации №46. ‒ г. Москва: «Научно-практический центр медицинской радиологии» департамента здравоохранения города Москвы 2018.
621. Sperduto P. W., Jiang W., Brown P. D., Braunstein S., Sneed P., Wattson D. A., Shih H. A., Bangdiwala A., Shanley R., Lockney N. A., Beal K., Lou E., Amatruda T., Sperduto W. A., Kirkpatrick J. P., Yeh N., Gaspar L. E., Molitoris J. K., Masucci L., Roberge D., Yu J., Chiang V., Mehta M. Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA) // Int J Radiat Oncol Biol Phys. ‒ 2017. ‒ T. 99, № 4. ‒ C. 812-816.
622. Sperduto P. W. Erratum to: Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M. Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA). Int J Radiat Oncol Biol Phys 2017;99:812-816 // Int J Radiat Oncol Biol Phys. ‒ 2024. ‒ T. 120, № 4. ‒ C. 1197.